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Abstract
Polarized microtubule (MT) growth in the leading edge is critical to directed cell migration, and is mediated by Rac1 GTPase.
To find downstream targets of Rac1 that affect MT assembly dynamics, we performed an RNAi screen of 23 MT binding and
regulatory factors and identified RNAi treatments that suppressed changes in MT dynamics induced by constitutively
activated Rac1. By analyzing fluorescent EB3 dynamics with automated tracking, we found that RNAi treatments targeting
p150
glued, APC2, spastin, EB1, Op18, or MARK2 blocked Rac1-mediated MT growth in lamellipodia. MARK2 was the only
protein whose RNAi targeting additionally suppressed Rac1 effects on MT orientation in lamellipodia, and thus became the
focus of further study. We show that GFP-MARK2 rescued effects of MARK2 depletion on MT growth lifetime and
orientation, and GFP-MARK2 localized in lamellipodia in a Rac1-activity-dependent manner. In a wound-edge motility assay,
MARK2-depleted cells failed to polarize their centrosomes or exhibit oriented MT growth in the leading edge, and displayed
defects in directional cell migration. Thus, automated image analysis of MT assembly dynamics identified MARK2 as a target
regulated downstream of Rac1 that promotes oriented MT growth in the leading edge to mediate directed cell migration.
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Introduction
Directed cell migration is fundamental to diverse physiological
processes, including developmental morphogenesis, cancer metas-
tasis, and the immune response. To directionally migrate, cells
must sense signals from the extracellular environment and
transduce the signals to downstream effectors that polarize the
cytoskeleton and regionally regulate its organization and dynamics
[1]. It is well established that the actin and microtubule (MT)
cytoskeletal systems are critical to directed cell movement. The
actin cytoskeleton is the primary force generator for cell migration:
Rapid polymerization of F-actin drives lamellipodia/lamella
protrusions in the cell leading edge, and contraction of acto-
myosin bundles in the cell body causes retraction of the trailing cell
rear [2].
The MT cytoskeleton is required for rapid, directed migration
of tissue cells [3], however its role in cell motility is less clear than
that of actin. MTs are thought to provide critical cell polarization
cues that dictate spatial regulation of protrusive and contractile
actin-based processes [3]. Indeed, the MT cytoskeleton displays a
characteristic polarized organization and dynamics in migrating
cells. MTs growing from the MT-organizing center (MTOC) and
Golgi apparatus orient towards the leading edge lamella/
lamellipodia region [3,4]. In addition, MT dynamic instability is
polarized in migrating cells. MTs in the lamellipodia grow more
slowly, persistently and parallel to the cell edge than those in the
lamella [5,6,7]. These leading edge MTs have been termed
‘‘pioneer MTs,’’ and in PtK epithelial cells, exhibit a decreased
catastrophe frequency (switch from growth to shrinkage), resulting
in an increased growth time [7]. Pioneer MTs are thought to guide
directed migration by localizing signals that promote lamellipodial
actin dynamics [8], and/or facilitating turnover of leading edge
focal adhesions [9]. However, the mechanisms that establish
pioneer MTs in the lamellipodia of migrating cells are not
understood.
The Rho family of small GTPases act as molecular switches that
locally control cytoskeleton dynamics through multiple effectors
[10]. In migrating cells, activated Rac1 accumulates in lamellipo-
dia and stimulates local actin polymerization to drive leading edge
protrusion [11,12]. In addition, we previously showed that
lamellipodial pioneer MTs can be induced by activation of Rac1
[7]. We identified two distinct pathways downstream of Rac1 that
promote pioneer MT growth. One depends on Rac1-mediated
activation of p21-activated kinase1 (Pak1), which phosphorylates
and inactivates the MT-destabilizing protein Op18/stathmin
[7,13]. Alternatively, Rac1-mediated inactivation of glycogen-
synthase kinase 3b (GSK3b) induces MT binding and growth
stabilization by CLASP [14,15]. However, in those studies, we
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sufficient for inducing pioneer MTs [7,13,15], indicating that
additional factors must regulate pioneer MTs downstream of
Rac1.
To find downstream targets of Rac1 signaling that promote
pioneer MTs, we performed an RNAi-based screen of MT
regulatory factors to identify proteins whose depletion suppresses
MT growth and orientation induced by constitutively activated
Rac1. For unbiased and statistically robust analysis of millions of
MT growth excursions in many cells across a range of conditions
(Tables S1, S3, S5, S7, S8), we utilized plusTipTracker, an
automated image analysis program that tracks motion of
fluorescent-tagged EB3, a MT plus-end binding protein (+TIP)
[16,17,18]. We identified six RNAi treatments that suppressed
Rac1-induced MT assembly dynamics, and one of these,
microtubule-affinity-regulating kinase2 (MARK2), that addition-
ally suppressed Rac1-mediated MT orientation in lamellipodia.
The MARK2 homologues are known to mediate organization of
MTs and polarity establishment in epithelia, oocytes and neurons
[19,20,21,22,23], but how MARK2 controls MT dynamics in cell
migration has not been demonstrated. Our results suggest that
MARK2 is required for polarization in migrating cells through
promotion of pioneer MTs downstream of Rac1.
Results
Rac1 Activity Promotes Pioneer MTs in Lamellipodia of
U2-OS Osteosarcoma Cells
We previously showed that Rac1 activation in PtK1 kidney
epithelial cells promotes formation of pioneer MTs, characterized
by persistent, slow plus-end growth in lamellipodia parallel to the
leading cell edge [7]. To identify downstream targets of Rac1 that
promote pioneer MTs, we sought to utilize an RNAi screening
approach with U2-OS osteosarcoma cells due to their human
origin and amenability to transfection. To validate the efficacy of
these cells for our purpose, we transfected them with a
constitutively activated Rac1 mutant (CA-Rac1) and analyzed
their MT organization and dynamics. Fluorescent localization of
F-actin showed that expression of CA-Rac1 in U2-OS cells
promoted lamellipodia formation and reduced stress fibers
compared to mock-transfected controls or cells expressing
dominant negative Rac1 (DN-Rac1) (Fig. 1A) and similar to
effects in other cell types [24]. Immunolocalization of MTs showed
that like previous studies in PtK1 cells, expression of CA-Rac1 had
a strong effect on MT organization, inducing a bundle of MTs
parallel to the cell edge in lamellipodia around most of the cell
periphery. In contrast, in controls and cells expressing DN-Rac1,
MTs were for the most part oriented perpendicular to the cell edge
and absent from lamellipodia. Thus, Rac1 activity promotes
formation of oriented lamellipodial MTs in U2OS cells, similar
other cell types [7].
To determine the effects of Rac1 activity on MT growth
dynamics, we performed live-cell imaging of the +TIP protein EB3
fused to monomeric Kusabira Orange (mKO-EB3, Video S1) as a
non-perturbing marker of growing MT plus ends [25,26] and used
plusTipTracker software package [16,17,18] for high-throughput
measurement of MT growth dynamics. Because +TIP proteins
only associate with MT ends during active growth excursions, we
were limited to measuring MT growth speed and growth
persistence lifetime, i.e. the duration of a growth excursion before
loss of fluorescent EB3 from the MT plus end due to transition to
shortening (catastrophe) or to pause [25]. Automated tracking is
powerful because of the ability to measure ,10,000–30,000 MT
growth excursions per condition (Tables S1, S3, S5, S8), allowing
robust statistical analysis that facilitates identification of treatments
that may have subtle, yet reproducible effects on MT growth. The
limitations and accuracy of this program are described in detail in
[16,17].
We classified MT growth excursions as ‘‘slow’’ vs. ‘‘fast’’ or
‘‘short-lived’’ vs. ‘‘long-lived’’ based on thresholds of the mean
value for each parameter from the population of all measurements
from non-targeting vector-transfected control cells (Fig. 1B,
[17,18]). These classes of MT growth dynamics were color-coded
and the percentage of growth excursions in each class in the
measured population was depicted as a bar graph to allow easy
visual assessment and comparison of the effects of perturbations on
MT growth dynamics across a range of conditions [17,18]. Mean
growth speeds and growth lifetimes, standard errors and the
number of cells and MTs analyzed, for all conditions in all figures
are presented in the Supplemental tables. We also generated
image overlays of color-coded MT growth tracks to allow
qualitative visualization of regional differences in MT growth
dynamics throughout the cell (Fig. 1B).
Analysis of MT growth with plusTipTracker software showed
that compared to control, CA-Rac1 expression increased the
proportion of slow, short-lived (red) MT growth excursions,
whereas expression of DN-Rac1 increased the proportion of fast,
short-lived (yellow) MT growth excursions (Fig. 1C, Table S2).
Changes in proportions of MTs in each class were mirrored by
changes in mean values, as CA-Rac1 decreased and DN-Rac1
increased MT growth speed, and either CA-Rac1 or DN-Rac1
reduced MT growth lifetime (Fig. 1D, 1E, Table S1) compared to
control. These results differ from previous results where CA-Rac1
was shown to inhibit catastrophe and thus promote longer-lived
MT growth [7]. This discrepancy could arise from the technical
improvements afforded by our current methodology including
automated tracking of EB3 comets compared to hand-tracking
fluorescent tubulin in our previous studies [5,7]. These improve-
ments include a shorter image acquisition frequency, which would
allow measurement of shorter-lived growth excursions than the
previous study, and higher accuracy localization of the MT end,
which would allow measurement of slower growth that may have
been counted as pause in the previous study. Moreover, manual
measurements of MT dynamics tend to focus on longer-lived
growth phases. These subjective biases are reduced by automated
tracking approaches. Alternatively, Rac1 activity may promote
subtle differences in MT dynamic instability depending on cell
type. Nonetheless, the overall phenotype of CA-Rac1 expression,
with extended MTs running parallel to the cell edge in the
lamellipodia are similar in both studies, indicating that Rac1
activity generates major effects on MTs in multiple cell types.
We next examined the spatial distribution of MT growth
induced by CA-Rac1. Given that pioneer MTs grow parallel to
the leading edge [5], we classified the orientation of MT growth
tracks within 5 mm of the cell edge as ‘‘parallel’’ (0–45u)o r
‘‘perpendicular’’ (45–90u, Fig. 1G, Table S7). This analysis and
examination of image overlays of color-coded MT growth tracks
(Fig. 1F) showed that CA-Rac1 promoted slow MT growth (red
and green) in the cell periphery parallel to the cell edge, and long-
lived MT growth (blue and green) in the cell center. In contrast,
controls and cells expressing DN-Rac1 displayed fast, long-lived
MT growth (blue) in the cell center, and both fast and slow, short-
lived MT growth (red and yellow) perpendicular to the leading
edge at the cell periphery. Thus, our results show that activated
Rac1 mediates pioneer MT formation in U2-OS cells at least in
part by promoting slow, short-lived MT growth excursions in
lamellipodia parallel to the cell edge, thus allowing for the basis of
a phenotypic screen.
MARK2 Regulates Microtubules Downstream of Rac1
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Dynamics Downstream of Rac1 in U2-OS Osteosarcoma
Cells
To find downstream targets of Rac1 that promote pioneer MTs,
we performed RNAi-based depletion of 23 MT-regulatory factors
(Figs. 2 and 3) and screened for proteins whose depletion
suppresses the slow, short-lived MT growth parallel to the leading
edge induced by CA-Rac1 in U2-OS cells (Fig. 3). We focused our
screen on non-motor MT-binding target proteins that are known
to regulate MT growth behavior, but it is unknown if they are
regulated by Rac1. These included APC, APC2, ACF7, CLASP2,
Figure 1. Rac1 promotes pioneer MTs in U2-OS cells. (A) Immunolocalization of microtubules (MTs) and fluorescent phalloidin staining of F-
actin in mock-transfected cells (control) or cells expressing CA-Rac1 or DN-Rac1. Contrast inverted, left, center. Zoom of boxed region, second
column. Insets, BFP-Rac1. Bar, 10 mm. (B) Workflow of plusTipTracker software for detecting mKO-EB3 comets, tracking them, and classifying MT
growth excursions. (C) Top: Proportion of MT growth excursions in each subpopulation in non-targeting control vector, CA-Rac1 or DN-Rac1
expressing cells. Bottom: Color key showing MT growth speed and growth excursion lifetime ranges for subpopulations. Box-plots of speed (D) and
lifetime (E) of MT growth excursions, conditions as in C. (*, p,0.001, Kolmogorov-Smirnov, *, p,0.05, Students). (F) Top: mKO-EB3 tracks from 2 min
time-lapse movies (frame rate =3 s) colored according to the key in C overlaid on images of mKO-EB3 (inverted contrast), conditions described in A.
Bottom: zoom of boxed region. Bars, 10 mm. (G) Percentage of MT growth tracks within 5 mm from the leading edge whose angle relative to the edge
is between 0–45u (blue) or between 45–90u (green), conditions as in C.
doi:10.1371/journal.pone.0041413.g001
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glued, p50/dynamitin, doublecor-
tin, EB1, katanin p60 subunit, MARK1, MARK2, MARK3,
MAP1A, MAP1B, MAP1S, MAP2, MAP4, STOP, spastin, or
Op18/stathmin. shRNA vectors were used for RNAi targeting of
EB1, CLASP2, dynamitin, DCX, MAP1A, MAP1B, MAP2,
MAP4, MARK1, MARK2 and MARK3. siRNA oligos were used
for RNAi targeting of APC, APC2, ACF7, XMAP215, Op18,
p150
glued, CLIP115, CLIP170, STOP, MAP1S, spastin and
katanin p60 (see Methods). Op18/stathmin and CLASP that are
both known to regulate MT dynamics downstream of Rac1 in
other cell types [13,15] were included as positive controls. We used
plusTipTracker to analyze the speed, lifetime, and orientation of
MT growth excursions in movies of cells expressing mKO-EB3
and treated with either siRNAs or shRNAs targeting (see Methods)
one of these MT regulatory proteins together with (Fig. 3A, Tables
S5, S6) or without (Fig. 2, Tables S3, S4) the additional expression
of CA-Rac1. Expression of target proteins in U2OS cells was
verified for as many target proteins as possible (see methods),
however in many cases antibodies were not available. Thus,
negative results in this screen should be interpreted with caution.
We first analyzed the effects of RNAi treatments targeting MT
regulatory proteins in the absence of CA-Rac1. As expected,
RNAi treatment targeting most of these MT regulatory proteins
induced alterations of MT growth behavior compared to non-
targeting RNAi controls (Fig. 2, see Methods). RNAi treatments
targeting either the +TIP rescue factor CLIP115/170 [27], the
XMAP215 protein that promotes rapid MT assembly and
disassembly [28], the MT stabilizer and assembly factor DCX
[29], the plus end anchor and MT stabilizing protein APC2
[30,31], the MT growth enhancer MAP1S [32] or the MT
stabilizer STOP [33] resulted in a greater fraction of both slow
short-lived (red) and slow long-lived (green) MT growth excursions
compared to control. This suggests that these proteins promote fast
MT growth in U2-OS cells, and confirms demonstrated
(XMAP215 [28], DCX [29]) and suggested (STOP [33], MAP1S
[32], APC2 [34]) functions of several of these proteins from
previous studies in other cell types. RNAi treatments targeting
either the dynactin subunit p50/dynamitin, the MT stabilizer
MAP2, the microtubule affinity regulating kinases (MARK1,
MARK2, MARK3) that promote MT disassembly [35], the
catastrophe factor Op18/stathmin [36], the MT severing protein
katanin p60 [37], the MT-actin crosslinking and catastrophe-
promoting protein ACF7 [38], or the MT growth stabilizer
CLASP2 [39] resulted in a greater fraction of both fast short-lived
(yellow) and fast long-lived (blue) MT growth excursions compared
to control. This suggests that these proteins slow or inhibit MT
growth in U2-OS cells, and confirms demonstrated (Op18/
stathmin [36], katanin [37], ACF7 [38]) and suggested (MARKs
[35], CLASP [39]) functions of these proteins from previous
studies in other cell types. RNAi treatments targeting each of the
remaining proteins (the +TIP EB1, the MT severing protein
Spastin, the assembly promoting MAP1 family members (MAP1A
and MAP1B), the dynactin subunit p150
glued, and the growth-
promoting +TIP APC had little effect on the rate or duration of
MT growth excursions, suggesting possibly inefficient RNAi
targeting, low protein expression in U2-OS cells, the presence of
redundant proteins (i.e. APC2, EB3, MAP1s), or cell type-specific
effects. Differences in expected effects of RNAi treatment on MT
dynamics based on previous studies (i.e. CLIP115/170, MAP2)
could be due to similar issues with RNAi targeting and/or cell type
specificity. However, in general, these results demonstrate that
depletion of known MT regulatory proteins produces expected
effects on U2-OS MT growth dynamics.
To identify proteins whose depletion suppresses the slow, short-
lived MT growth parallel to the leading edge induced by CA-
Rac1, we then determined the effects of RNAi treatments
targeting MT regulatory proteins in the presence of activated
Rac1. We considered a ‘‘hit’’ based on three criteria. First, because
the percentage of slow, short-lived (red) MT growth tracks was
increased in cells expressing CA-Rac1 (Fig. 1C, 51%) compared to
controls (38%), we sought targets whose RNAi treatment reduced
the percentage of slow, short-lived (red) MT growth tracks in cells
expressing CA-Rac1 to less than 50% (black dashed line, Fig. 3A).
RNAi treatments meeting this criterion included those targeting
dynactin subunits (p50/dynamitin, p150
glued), MAPs (MAP4,
MAP1B, MAP2), MT severing proteins (Spastin, katanin p60),
MT plus end-binding proteins (EB1, APC2, CLASP2), the MT
depolymerizing factor Op18/stathmin, the cytoskeletal linker
ACF7, and MARK2 (Table S6). Our identification of Op18 and
CLASP, previously known targets of Rac1 regulation [13,15],
validates the efficacy of our automated MT analysis and selection
criteria approach. Second, because CA-Rac1 increased the total
proportion of slow-growing MTs (red+green, 65%) compared to
control (red+green, 52%), our second criteria for a ‘‘hit’’ was an
Figure 2. Effects of MT regulatory protein depletion on MT
growth dynamics in U2-OS cells. Top: Results of analysis of time-
lapse movies of mKO-EB3 with PlusTipTracker software. Proportion of
MT growth excursions in each subpopulation in control shRNA vector-
transfected cells (WT) or cells treated with RNAis targeting the protein
noted (kd). shRNA vectors were used for RNAi targeting of EB1, CLASP2,
dynamitin, DCX, MAP1A, MAP1B, MAP2, MAP4, MARK1, MARK2 and
MARK3. siRNA oligos were used for RNAi targeting of APC, APC2, ACF7,
XMAP215, Op18, p150
glued, CLIP115, CLIP170, STOP, MAP1S, Spastin and
Katanin p60 (see Methods). Bottom: Color key showing MT growth
speed and growth excursion lifetime ranges for each subpopulation.
doi:10.1371/journal.pone.0041413.g002
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(red+green) in cells expressing CA-Rac1 to between 40% and 60%
(black lines, Fig. 3A). RNAi treatments meeting both criteria
included those targeting p150
glued, APC2, Spastin, EB1, Op18, and
MARK2 (Table S6), suggesting that these proteins are required for
the slow, short-lived MT growth induced by CA-Rac1.
Figure 3. RNAi screen for proteins whose depletion blocks CA-Rac1 effects on MT growth and orientation. (A) Top: Proportion of MT
growth excursions in each subpopulation in control shRNA vector-transfected cells (control), cells expressing CA-Rac1, CA-Rac1 and additionally
treated with RNAis targeting the protein noted (kd), DN-Rac1. shRNA vectors were used for RNAi targeting of EB1, CLASP2, dynamitin, DCX, MAP1A,
MAP1B, MAP2, MAP4, MARK1, MARK2 and MARK3. siRNA oligos were used for RNAi targeting of APC, APC2, ACF7, XMAP215, Op18, p150
glued,
CLIP115, CLIP170, STOP, MAP1S, Spastin and Katanin p60 (see Methods). Dashed line 1: proteins which pass the first criteria (red tracks,50%); solid
line 2: proteins which pass the second criteria (40%,red+green tracks ,60%). Bottom: Color key showing MT growth speed and growth excursion
lifetime ranges for subpopulations. (B) mKO-EB3 tracks from 2 min time-lapse movies (frame rate=3 s) colored according to the key in A overlaid on
images of mKO-EB3 (inverted contrast) in cells treated with RNAis targeting the noted proteins with (bottom) or without (top) CA-Rac1 expression.
Bar, 10 mm. (C) Percentage of MT growth tracks within 5 mm from the leading edge whose angle relative to the cell edge is between 0–45u (blue) or
between 45–90u (green), conditions as in B.
doi:10.1371/journal.pone.0041413.g003
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whose RNAi targeting additionally suppressed the effects of CA-
Rac1 on MT orientation in the lamellipodium. We analyzed
image overlays of color-coded MT growth tracks in cells
expressing CA-Rac1 and treated with siRNAs or shRNAs
targeting p150
glued, APC2, spastin, EB1, Op18 and MARK2
(Fig. 3B, 3C, Table S7). Of these, only cells expressing CA-Rac1
and shRNA targeting MARK2 showed a reduction in MTs
oriented parallel to the leading edge compared to cells expressing
CA-Rac1 alone. Together, these results suggest that MARK2 may
be a key Rac1 target promoting leading edge pioneer MTs by
regulating both MT growth speed and lifetime as well as growth
orientation in the cell periphery.
MARK2 Promotes Short-lived MT Growth Parallel to the
Cell Edge Downstream of Rac1
We next sought to validate the results of our RNAi screen
suggesting that Rac1’s effects on MT dynamics and orientation
are mediated by MARK2. Western blot of U2-OS cell lysates
showed that either shRNA or siRNA effectively depleted
MARK2 protein (Fig. 4A, lanes 2 and 5) and expression of
an shRNA-resistant GFP-tagged MARK2 in cells expressing
MARK2-specific shRNA restored near wild-type protein level
(Fig. 4A, lane 3). In fixed cells, both the elongated MTs in
lamellipodia parallel to the cell edge and the discoid cell
morphology induced by CA-Rac1 were abolished by shRNA-
mediated MARK2 depletion, and MT organization and cell
morphology were rescued by re-expression of GFP-MARK2
(Fig. 4B). Analysis of MT growth dynamics via tracking mKO-
EB3 (Video S2) showed that shRNA-mediated MARK2
depletion in cells expressing CA-Rac1 increased the proportion
of fast, long-lived (blue) MT growth and decreased slow, short-
lived (red) growth (Fig. 3A, 4C, Table S2), increasing mean MT
growth speed and lifetime compared to cells expressing CA-
Rac1 alone, and similar to these values in control shRNA
treated-cells (Fig. 4D, 4E, Table S1). Expression of GFP-
MARK2 in shRNA-mediated MARK2-depleted, CA-Rac1-
expressing cells rescued the effects of MARK2 depletion on
MT growth lifetime (Fig. 4E) and growth orientation in
lamellipodia (Fig. 4F, 4G, Table S7). However, despite rescue
of MT growth lifetime and orientation, expression of GFP-
MARK-2 in MARK2 shRNA-treated cells further increased
MT growth speed compared to cells expressing CA-Rac1 alone
(Fig. 4D). To determine if the increased MT growth speed was
due to an off-target effect, we tested to see if an shRNA
targeting a distinct sequence in MARK2 had similar effects on
MT dynamics ([40], Fig. S1, Tables S1 and S8). This showed
that both shRNAs had similar effects: increases in both MT
growth speed and lifetime, and expression of GFP-MARK2
rescued the increased MT growth lifetime but showed further
increase of MT growth speed (Fig. 4D, 4E, Fig. S1, Table S8).
This suggests that MT growth speed may be tightly regulated
by a specific MARK2 protein level [41]. However, these results
show that MARK2 promotes pioneer MT formation in
lamellipodia downstream of activated Rac1, at least in part by
inducing short-lived MT growth excursions parallel to the cell
edge.
MARK2 is Required for Pioneer MTs in the Leading Edge
and Polarized Cell Migration
We then characterized the function of MARK2 in U2OS cells,
comparing its role in MT organization and dynamics in non-
polarized and polarized migrating cells. Staining of MTs in fixed
non-polarized cells showed that neither shRNA-mediated
MARK2 depletion nor re-expression of GFP-MARK2 in
MARK2-depleted cells substantially affected overall MT organi-
zation (Fig. 5A). However, analysis of MT growth dynamics via
tracking mKO-EB3 (Video S2) showed that MARK2 depletion
did, in fact, affect MT dynamics in non-polarized cells. As noted,
MARK2 shRNA treatment increased the proportion of fast, long-
lived MT growth excursions (blue) and reduced the proportion of
both slow short-lived and slow long-lived growth excursions (red
and green, Fig. 2, Fig. 5B, Table S1), increasing both speed and
lifetime of MT growth (Fig. 5C, 5D, Table S2). Expression of
GFP-MARK2 in MARK2-depleted non-polarized cells increased
the proportion of fast, short-lived MT growth excursions (yellow),
rescuing the effects of MARK2 depletion on MT growth lifetime,
but further increased MT growth speed compared to control
(Fig. 5B–D). This is similar to effects of rescuing MARK2
depletion with GFP-MARK2 in the presence of CA-Rac1
(Fig. 4D, 4E, Video S2), supporting the notion that RNAi effects
on MT lifetime were MARK2-dependent and effects on growth
speed may be dependent on the specific level of MARK2 protein
or were MARK2 independent. Analysis of the spatial organization
of MT growth excursions in image overlays of color-coded MT
growth tracks showed that in non-polarized cells, neither shRNA-
mediated MARK2 depletion nor re-expression of GFP-MARK2
in MARK2 depleted cells substantially affected the spatial
distribution or orientation relative to the cell edge of MT growth
excursions (Fig. 5E, 5F, Table S7). Thus, although MARK2
clearly regulates MT growth lifetime and orientation in lamelli-
podia downstream of activated Rac1, in non-polarized cells in the
absence of exogenous Rac1 activation, MARK2 promotes short-
lived MT growth excursions, but has little effect on MT
organization or growth orientation.
To resolve these apparently disparate results, we sought to
determine if MARK2 specifically functions in spatial organiza-
tion of MT growth in polarized cells undergoing directed
migration in a scratch wound assay, where Rac1 activity has
been shown to be polarized towards the leading edge in other
cell types [11]. We analyzed MT growth in polarized cells
migrating at a wound edge, comparing MT growth parameters
averaged from whole cells (W) to MT growth parameters from
within 5 mm of the leading edge (LE). In control shRNA
treated-wound-edge cells, MTs in the leading edge exhibited
more slow and short-lived growth excursions that were more
often parallel to the cell edge compared to MTs throughout the
whole cell, typical of pioneer MTs and similar to the effects of
CA-Rac1 on MT growth (Fig. 6A–E, Tables S1, S2, S7, Video
S3). shRNA-mediated MARK2 depletion in wound-edge cells
homogenized differences in MT growth speed between MTs at
the leading edge and throughout the whole cell, increased MT
growth lifetime in both the leading edge and whole cell, and
reduced the proportion of MTs growing parallel to the cell edge
compared to controls or cells expressing CA-Rac1 (Fig. 6A–E,
Tables S1, S2, S7, Video S3). Thus, MARK2 is required for
polarizing MT growth dynamics to form pioneer MTs that
exhibit slow, short-lived growth parallel to leading lamellipodia
in polarized, directionally migrating cells.
We then sought to determine whether localization of MARK2 is
polarized in migrating cells and/or controlled by Rac1 activity
(Fig. 7). Unfortunately, available antibodies to MARK2 were not
effective for immunofluorescnce under conditions required to
preserve MT structure in fixed U2-OS cells. Comparing mCherry
fluorescence as a volume marker to expressed GFP-MARK2
showed that GFP-MARK2 accumulated in protrusive regions of
non-polarized cells (Fig. 7A). In migrating cells at a wound edge
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was concentrated in the single leading protrusion facing the
direction of migration (Fig. 7B). Co-expression of GFP-MARK2
and Rac1 mutants showed that CA-Rac1 induced concentration
of GFP-MARK2 in lamellipodia around the entire cell periphery,
and all peripheral localization was abolished in cells expressing
DN-Rac1 (Fig. 7C). Thus, MARK2 localizes to the leading edge of
Figure 4. MARK2 regulates MT growth dynamics and orientation downstream of Rac1. (A) Western blot of lysates of U2-OS cells
transfected with control shRNA (lane 1), MARK2-shRNA (lane 2), MARK2-shRNA and shRNA-resistant GFP-MARK2, (lane 3), non-targeting siRNA pool
(lane 4) or MARK2 siRNA (lane 5). GAPDH and DM1A were used as a loading control. (B) Immunostaining of MTs (inverted contrast) in cells expressing
BFP-CA-Rac1 (Rac1) and GFP-shRNA targeting MARK2 (shRNA), or rescued with GFP-MARK2 expression. Center column: zoom of boxed region. (C)
Top: Proportion of MT growth excursions in subpopulations, conditions as in B. Control represents control shRNA vector transfected cells. Bottom:
Color key showing MT growth speed and growth excursion lifetime ranges for subpopulations. Box-plots of speed (D) and lifetime (E) of MT growth
excursions, conditions as in B. (*p,0.001, Kolmogorov-Smirnov, *p,0.05, Students). (F) Top: mKO-EB3 tracks from 2 min time-lapse movies (frame
rate=3 s) colored according to the key in C overlaid on images of mKO-EB3 (inverted contrast), conditions as in B. Bottom: Zoom of boxed regions.
(G) Percentage of MT growth tracks within 5 mm from the leading edge whose angle relative to the cell edge is between 0–45u (blue) or between 45–
90u (green), conditions as in B. Bars, 10 mm.
doi:10.1371/journal.pone.0041413.g004
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suggesting MARK2 regulates MT organization in these regions.
We finally sought to determine the role of MARK2 in
polarization and directional migration of U2-OS cells. To assay
cell polarization, we examined effects of siRNA-mediated
MARK2 depletion on centrosome orientation by immunolocaliz-
ing c-tubulin in cells in a scratch wound assay. We utilized siRNA-
mediated targeting in this experiment because of its increased
transfection efficiency compared to shRNA. This allowed better
determination of effects of MARK2 depletion on monolayer
wound healing, which is coordinated by all cells in the monolayer,
and may not be apparent with the lower level transfection afforded
Figure 5. MARK2 regulates MT growth lifetime. (A) Immunolocalization of MTs (inverted contrast) in cells expressing control shRNA-GFP (top),
MARK2 shRNA-GFP (middle), or MARK2 shRNA-GFP together with RNAi-resistant GFP-MARK2 (bottom). Cells co-expressing MARK2 shRNA-GFP and
GFP-MARK2 could be recognized by the targeting of GFP-MARK2 to the centrosome (arrowhead). (B) Top: Proportion of MT growth excursions in
each subpopulation in cells under the conditions described in A. Bottom: Color key showing MT growth speed and growth excursion lifetime ranges
for subpopulations. Box-plots of speed (C) and lifetime (D) of MT growth excursions, conditions as in A. (*, p,0.001, Kolmogorov-Smirnov, *, p,0.05,
Students) (E) Top: mKO-EB3 tracks from 2 min time-lapse movies (frame rate=3 s) colored according to the key in B overlaid on images of mKO-EB3
(inverted contrast), conditions as in A. Bottom: zoom of boxed regions. (F) Percentage of MT growth tracks within 5 mm from the leading edge whose
angle relative to the cell edge is between 0–45u (blue) or between 45–90u (green), conditions as in A. Bars, 10 mm.
doi:10.1371/journal.pone.0041413.g005
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directed migrating cells. (A) Above: Proportion of MT growth
excursions in each subpopulation in control shRNA vector-transfected
whole cells (W), expression of CA-Rac1, MARK2 shRNA treatment or
from within 5 mm from the leading edge of wound edge cells with
MARK2 shRNA (MARK2 RNAi (LE)) or control shRNA (control (LE))
treatment. Below: Color key showing MT growth speed and growth
excursion lifetime ranges for subpopulations. Box-plots of speed (B) and
lifetime (C) of MT growth excursions, conditions as in A. (*, p,0.001,
Kolmogorov-Smirnov, *, p,0.05, Students). (D) mKO-EB3 tracks from
2 min time-lapse movies (frame rate=3 s) of cells at the edge of a
scratch-wound, colored according to the key in A overlaid on images of
mKO-EB3 (inverted contrast) with MARK2 shRNA (MARK2 RNAi) or
control shRNA (control RNAi) treatment. Only MT growth tracks that
come within 5 mm of the leading edge are shown. Bar, 10 mm. (E)
Percentage of MT growth tracks within 5 mm from the leading edge
whose angle relative to the cell edge is between 0–45u (blue) or
between 45–90u (green), conditions as in A.
doi:10.1371/journal.pone.0041413.g006
Figure 7. Accumulation of MARK2 in the leading edge depends
on Rac1 activity. (A) Fluorescence images of GFP-MARK2 (upper left),
mCherry-C1 (upper right) and phase image (lower left) in a non-
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MARK2-depleted cells were inhibited in forward orientation of
centrosomes, and MTs were less extended towards the leading
edge compared to non-targeting siRNA treated-control cells
(Fig. 8A, 8B). Analysis of time-lapse phase contrast movies showed
that MARK2 depletion caused wound-edge cells to migrate
significantly more slowly and with reduced directional persistence
compared to control (Fig. 8C–F, Video S4, [42]). Together, these
results suggest that MARK2 promotes directed cell migration via
establishing polarity of the MT cytoskeleton and enhancing
pioneer MT growth in the leading edge.
Discussion
We utilized automated image analysis algorithms to screen for
regulators of MT assembly dynamics induced downstream of
Rac1 activation. Our results suggest that Op18/stathmin, the
dynactin component p150
glued, the +TIP proteins APC2 and
EB1, the MT severing enzyme Spastin, and the kinase MARK2
may be potential downstream mediators of Rac1 signaling that
regulate MT dynamics. Mechanistic links between Rac1 and
APC or Op18 have previously been reported [13,43], however
the other factors identified here represent novel potential Rac1
targets. Thus, our results suggest that Rac1 acts as a master
regulator of leading edge MT dynamics through multiple
molecular pathways.
Our study represents the first time that parameters of MT
growth dynamics have been used as the basis of a phenotypic
screen, and was made possible by the development of
automated image analysis programs [16,17,18]. This method
allowed measurement of MT growth excursions throughout the
cell, including short-lived, slow growth excursions that were not
measurable by hand-tracking in previous studies [7], suggesting
that activated Rac1 primarily promotes less persistent and
slower polymerization of MTs, especially in the leading edge
(Fig. 1C–E).
By further analyzing MT growth orientation in lamellipodia,
we identified a single protein, MARK2, as required for Rac1
effects on both MT growth dynamics and orientation mediating
pioneer MT formation. MARK2 is the mammalian homologue
of the polarity protein PAR-1 which is thought to mediate
polarity through effects on MTs [44]. However, this is the first
report of MARK2/PAR1’s effects on polarity and MT
dynamics being controlled by the Rac1 signaling cascade. We
found that RNAis targeting any of the three MARK isoforms
(1, 2, and 3) promoted fast MT assembly, suggesting that
MARKs function to slow MT growth or destabilize MTs in
situ, in agreement with previous studies [35]. Interestingly,
depletion of MARK 1, 2 or 3 suppressed the slow, short-lived
growth induced by CA-Rac1, but only depletion of MARK2
suppressed the effects of Rac1 on MT orientation in lamelli-
podia. Taken together, this suggests that all three MARK
isoforms function downstream of Rac1 to regulate MT growth,
but MARK2 additionally regulates Rac-1 mediated MT
orientation.
The molecular mechanism by which Rac1 promotes MARK2-
mediated regulation of MT growth dynamics and orientation in
the leading edge is of interest. MARK2 is known to be activated by
phosphorylation [23], and active MARK2 in turn phosphorylates
MT-associated proteins (MAPs) such as tau, MAP2 and MAP4,
which causes them to dissociate from MTs [23,45,46]. Notably, we
found that RNAis targeting several MAPs including MAP4,
MAP1B and MAP2, reduced the proportion of slow, short-lived
MT growth excursions (Fig. 3A), similar to the effects of MARK2
depletion. Further study is needed to determine if Rac1 mediates
local downstream inactivation of MARK2 in lamellipodia to
reduce MAP phosphorylation and promote MAP-MT binding to
locally stabilize MTs and drive pioneer MT growth. In addition,
although we showed that Rac1 activity controls MARK2
localization and Rac1’s effects on MTs require MARK2, it would
be of interest to additionally know if Rac1 controls MARK2’s
kinase activity. MARK2 has been shown to interact with the Rac1
targets, GSK3b and a PAK kinase [41,47,48], and these in turn
regulate Op18/stathmin and CLASP [13,15]. This suggests that
the MARK2, GSK3b, and PAK pathways of MT regulation could
intersect downstream of Rac1.
The question of how MARK2 regulates MT orientation in
lamellipodia is unclear. Since MT bending and growth parallel to
the cell edge is thought to be driven by MT interactions with
lamellipodial F-actin retrograde flow [5,49], it is possible that
MARK2’s effect on pioneer MT orientation are mediated by
phosphoregulation of MAPs that bind both MTs and actin, as has
been demonstrated for ACF7, APC and MAP2
[38,50,51,52,53,54]. Alternatively, MARK2 may coordinately
regulate MT and actin cytoskeletal dynamics through Pak kinases,
which target both MT and actin binding proteins [55].
Our study builds on previous work showing that MARK
kinases and their PAR1 homologues regulate cell polarity
through downstream effects on MTs [44]. In a recent study
of dendritic spines, it was found that that knockdown of the
MARK2 homologue PAR-1 decreased the distance and
duration of MT growth, as analyzed by tracking fluorescent
+TIP proteins [56]. This contrasts our study in which MT
growth persistence was increased in MARK2 knock-down cells
(Figs. 3, 4 and 5). This suggests that MARK2 may utilize
distinct effectors to control MT dynamics differently in each
system. Notably, tracking of GFP-EB3 dynamics in Drosophila
wing epidermis [57] and oocytes [58] revealed that the MARK2
homologue, Par-1, plays a crucial role in establishing a small
bias in the orientation of growing MTs without a substantial
change in overall MT distribution, resulting in asymmetric
segregation of polarity proteins. In addition, similar to
lamellipodia in migrating cells, MTs tend to bend and grow
along the posterior cortex of Drosophila oocytes where Par-1
localizes, and Par-1 mutants fail to show these polarized MT
growth excursions [58]. These data indicate that MARK2/
PAR-1 has a conserved role in organizing MTs and regulating
their growth and orientation in many systems.
Consistent with the role of MARK2 in MT reorganization,
our results demonstrate that MARK2 is essential for cell
polarization and directed cell migration. We found that
MARK2-depleted cells in a wound edge have reduced pioneer
polarized cell. Line scans (lower right) show the average normalized (to
maximal) fluorescent intensity of three different cells expressing GFP-
MARK2 (red) and mCherry-C1 (blue) along lines places similarly as those
shown in the upper panel. Arrow represents cell protrusion. (B)
Fluorescence image of GFP-MARK2 (upper left), and phase image
(upper right) in migrating cell at a wound edge. Arrow: cell protrusions,
Asterisks: cell-cell junctions. Line scans (lower panel) show average
normalized (to maximal) fluorescent intensity of lines in three different
cells expressing GFP-MARK2 along protrusion area (Lines 1) or non-
protrusion area (Line 2). (C) Fluorescence images of GFP-MARK2 (upper
left and upper right) in cell expressing BFP-CA-Rac1 (inset upper left) or
BFP-DN-Rac1 (inset upper right). Insets show the BFP fluorescence
images. Line scans indicate average normalized (to maximal) fluores-
cent intensity of three different cells expressing GFP-MARK2 along lines
placed similarly to those in in CA-Rac1 (left) or DN-Rac1 (right). Bars,
10 mm.
doi:10.1371/journal.pone.0041413.g007
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(Fig. 6). Indeed, depletion of MARK2 caused a failure in
centrosome polarization towards the wound edge, and inhibited
migration velocity and directionality (Fig. 8). MARK2/PAR-1
has also been shown to play a crucial role in directed migration
in other cell types. For example, in the cerebral cortex, neurons
depleted of MARK2 exhibit altered directed migration and
reduced centrosome motility [59]. In addition, par-1 null
mutants in Drosophila border cells also fail in directed cell
migration, showing abnormal protrusion in their front [60].
Therefore, MARK2/PAR-1 is a conserved key mediator for
establishing cell polarity during directed migration, likely
through regulating MT dynamics under the control of Rac1.
Taken together, our study shows the power of high-resolution,
quantitative live cell imaging assays for refined screening of protein
function, and identifies MARK2 as essential for linking Rac1
activation to polarization of MTs and their assembly dynamics
critical to directed cell migration.
Materials and Methods
CDNA Expression Constructs
PCR products and products of restriction digests were purified
by gel electrophoresis and extraction using the QIAquick
TM gel
extraction kit (QIAGEN, Valencia, CA, USA). Plasmid DNA was
purified from overnight cultures using the QIAprep
TM Spin
Miniprep kit (QIAGEN). Restriction endonucleases were pur-
chased from Life Technologies (Grand Island, NY, U.S.A.) or New
England Biolabs (Ipswich, MA, U.S.A.). Sequencing was used to
confirm the complete cDNA sequence (Florida State University
Bioanalytical and Molecular Cloning DNA Sequencing Labora-
tory). mKusabira Orange (mKO) fused to EB3 was constructed
using a N1 (Clontech-style) cloning vector. The fluorescent protein
cDNA was PCR amplified (Phusion Flash; Finnzymes, Espoo,
Finland) with a 59 primer encoding an AgeI site and a 39 primer
encoding a NotI (N1) site. The purified and digested PCR
products were ligated into a similarly digested EGFP-N1 cloning
vector backbone (Clontech, Mountain View, CA, U.S.A.). Human
EB3 cDNA (gift of Lynne Cassimeris, Lehigh University;
NM_012326.2) was PCR amplified (Phusion Flash) with primers
Figure 8. MARK2 is required for cell polarization and directional migration. (A) Immunostaining of MTs (left and right) and c-tubulin
(merge in center) in wound edge cells in non-targeting siRNA pool (top, control RNAi) and MARK2 siRNA treatment (bottom, MARK2 RNAi). Dotted
circles, centrosome; bar, 10 mm. (B) Percentage of cells in the wound edge with centrosomes in front of the nucleus. In B, D, F *p,0.05, Student’s t-
test. (C) Wound-healing assay in non-targeting siRNA pool (control RNAi; left) or MARK2 siRNA (MARK2 RNAi; right), time after wounding shown.
Dashed line, position of wound edge at t=0. Bar, 50 mm. (D) Average migration velocity of non-targeting siRNA pool (control) and MARK2 siRNA-
treated (MARK2 RNAi) cells. (E) Rose plots of the position of nuclei over 5 hr (each cell track colored differently) for non-targeting siRNA pool-(above,
control RNAi) or MARK2 siRNA-treated cells (below, MARK2 RNAi) at the edge of a wound. Arrows: open region of wound. (F) Distance from origin
(position at time=0) divided by total distance travelled over 5 hr for non-targeting siRNA pool and MARK2 siRNA treated cells.
doi:10.1371/journal.pone.0041413.g008
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into the mKO-N1 cloning vector to produce a fusion with EB3
attached to the N-terminus of mKO separated by a 6-amino acid
linker. DNA for mammalian cell transfection was prepared using
the Plasmid Maxi kit (QIAGEN). Proper localization was
confirmed using widefield (Nikon 80i; TRITC filter set) and
spinning disk microscopy (Olympus DSUIX81; TRITC filter set).
RNAi-resistant MARK2 tagged with EGFP for rescue experi-
ments was constructed by cloning a BglII-KpnI fragment of
pENTR(tm)221-MARK2 (Invitrogen) into pEGFP-C1 (CLON-
TECH Laboratories, Inc., Mountain View, CA) and substituting
sequence (59-AATTATCGATAAAACG-39) for sequence (59-
GATCATTGACAAGACT-39, from GM Bioscience (Rockville,
MD)). Human Rac1 G12V and T17N cDNA (Missouri S&T
cDNA Resource Center, Rolla, MO) were PCR amplified with
primers containing with a 59 primer encoding an KpnI and a 39
primer encoding a ApaI restriction enzyme sites and ligated into
the BFP-tagC1 cloning vector to produce a fusion with Rac1
G12V or T17N attached to the C-terminus of BFP.
Cell Culture and Transfection
U2-OS cells were obtained from American Type Culture
Collection and maintained in McCoy’s 5A with 10% FBS and 1%
penicillin-streptomycin (Invitrogen, Carlsbad, CA) at 37uCi n5 %
CO2. For live imaging, medium was supplemented with 25 mM
HEPES pH=7.2 and 30 units/ml Oxyrase. Transfections were
performed with an nucleofector (solution kit V (Lonza, Walkers-
ville, MD)). For stable expression of fluorescent EB3, transfected
cells were selected for 2 weeks in media supplemented with
0.8 mg/ml G-418 (Invitrogen), and low level-expressing cells
collected by FACS.
Western Blot
Cells were lysed in 1X Laemmli sample buffer, separated on 4–
12 or 4–20% SDS-PAGE gels (Invitrogen), transferred to
immobilon-P membranes, and visualized by immunoblotting with
enhanced chemiluminescence (GE Healthcare, Piscataway, NJ)
with the following antibodies: Primary antibodies: Mouse anti-
tubulin (1:3,000, DM1A, Sigma-Aldrich, St. Louis, MO); rabbit
anti-Par1 (1:200, obtained from A. Suzuki, Yokohama-City
University, Yokohama, Japan); mouse anti-GAPDH (1:5,000, Cell
Signaling, Danvers, MA); rabbit anti-Op18 (1:1000, Agrisera,
Va ¨nna ¨s, Sweden); rabbit anti-X-orbit antibody (1:1000, obtained
from R. Heald, UC Berkley, Berkley, CA); and mouse anti-
p150
glued (1:1000, BD Biosciences, San Jose, CA). Secondary
antibodies: HRP-conjugated anti-mouse or rabbit (1:3,000,
Jackson ImmunoResearch Laboratories, Inc, West Grove, PA).
Immunofluorescence
Coverslips with bound cells were fixed in 4% paraformaldehyde
and 0.5% Glutaraldehyde (Electron Microscopy Science) in
PHEM buffer (60 mM PIPES, 27 mM HEPES, 10 mM EGTA,
8 mM MgSO4, pH7.0) for 20 minutes at room temperature,
permeabilized with 0.1% Triton X-100 in PHEM for 5 min, free
aldehydes were reacted with 0.1 M glycine for 5 min, cells were
washed 3x for 5 min in PBS, and blocked in blocking solution (2%
BSA IgG free and protease free in PBS; Jackson ImmunoResearch
Laboratories, Inc.). Coverslips were incubated with mouse anti-c
tubulin (1:200, AKT-15, Sigma-Aldrich) and/or rat anti-tubulin a
(1:300, YL 1/2, AbDSerotec, Oxford, UK) antibodies diluted in
blocking solution overnight in a humid chamber at 4uC, washed
3X for 5 min in PBS, incubated with fluorophore-conjugated
secondary antibodies (1:250, Jackson ImmunoResearch Labora-
tories, Inc.) and Alexa Fluor 655 phalloidin (1:400; Invitrogen) for
1 h, washed again, and mounted on a slide in mounting media
(Dako).
RNAi
U2-OS cells stably expressing mKO-EB3 were transfected by
Amaxa nucleofector with SMARTpool (3 mg siRNA, Thermo
Fisher Scientific, Lafayette, CO) or shRNA vector (1 mg DNA,
Thermo Fisher Scientific), and cultured for 24 h at 37uC with 5%
CO2. Control cells were either transfected with non-targeting pool
siRNA (D-001810, Thermo Fisher Scientific) (Fig. 8) or control
shRNA vector (Thermo Scientific,) (Figs. 1B–F, 2, 3, 4, 5, and 6).
The next day, cells were transfected with BFP-tagC1-Rac1V12
and replated on coverslips, and experiments were performed 14–
20 hours later to allow time for Rac1 expression. The following
SMARTpools were used: APC (APC: L-003869), APC2 (APC2: L-
009847), MACF1 (ACF7: L-013618), CKAP5 (XMAP215: L-
006847), STIMN1 (Op18: L-005152), DCTN (p150
glued:L -
012874), CLIP1 (CLIP170: L-005294), CYLN2 (CLIP115: L-
013511), MAP6 (STOP: L-026713), BPY2IP1 (MAP1S: L-
016881), SPAST (Spastin: L-014070) and KATNA1 (katanin
p60: L-005157, Thermo Scientific Open Biosystems). The
following shRNA vectors were used: EB1 (pSuper-EB1, obtained
from T. Wittmann, UCSF, San Francisco, CA), an shRNAmir-
GFP library (Thermo Fisher Scientific Open Biosystems ) included
shRNA vectors for CLASP2, DCTN2, DCX, MAP1A, MAP1B,
MAP2, MAP4, MARK1, MARK2 and MARK3. For depletion of
MARK2 in a scratch wound assay (Fig. 8), SMARTpools (L-
004260, Thermo Fisher Scientific) were used. For depletion of
MARK2 in Figure S1 and Tables S8, human par-1b shRNA
vector (obtained from A. Suzuki, [40]) was used. Western blot
analysis was performed to verify protein depletion for CLASP2,
p150
glued dynactin, Op18/stathmin, and MARK2.
Microscopy
mKO-EB3 dynamics were imaged on a Yokogawa spinning
disk confocal microscope system described in [18] using a 6061.4
NA Plan Apo oil immersion objective lens (Nikon). Images of EB3
dynamics were generated using illumination from the 561 nm
laser and were captured using a 500-ms exposure at 3 sec image
intervals for 3 min on a Coolsnap HQ2 cooled CCD (Photo-
metrics) operated in the 14-bit mode. Images of immunofluores-
cence, GFP-MARK2 and mCherry volume marker were acquired
using the same microscope system, using the 561 or 488 nm lasers
as appropriate. Microscope system automation was controlled with
Metamorph software (Molecular Devices).
For wound healing assays, cells were grown to confluency and
wounded 48 h after transfection by generating a longitudinal
scratch using a razor blade. After a 2 h recovery at 37uCi n5 %
CO2, phase-contrast images were acquired at 5-min intervals for
20 h on the microscope described above using a 2060.45 NA
phase objective and an 0.52 NA LWD condenser using
Metamorph’s Multi-dimensional Acquisition (MDA) software
module.
Image Analysis
MT growth dynamics were analyzed from EB3 time-lapse
movies using plusTipTracker [16,17] (http://lccb.hms.harvard.
edu/software.html). For this study MT shrinkage or pause events
were not estimated. Accordingly, we set the gap length to relatively
short intervals to limit the gap closing mechanism in the software
mostly to bridge short-term out-of-focus movements of the comets.
The following parameter set was used for all movies in the dataset:
maximum gap length, 5 frames; minimum track length, 3 frames;
search radius range, 8–12 pixels; maximum forward angle, 30u;
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fluctuation radius, 1 pixel.
To categorize EB3 tracks based on MT growth speed and growth
excursion lifetime, we utilized the tool within plusTipTracker called
‘Quadrant Scatter Plots.’Briefly,thefunction generatesa 2D scatter
plot of speed versus lifetime with each point representing a single
MT growth excursion defined by a single continuous EB3 track.
Then, the points on the graph are divided into four subpopulations
based on whether they were above or below the average growth
speed (13 mm/min) and average growth lifetime (18 sec) of all EB3
tracks from all control cells analyzed in the study. These four
subpopulations are coded by color, and a percentage bar showing
the relative proportion of the subpopulations was generated.
Colored tracks were overlaid on an inverted image of mKO-EB3
using the same color scheme to show how each subpopulation is
distributed across the cell. To analyze the angle of MT growth
excursions near the leading edge, EB3 tracks in these color overlays
were analyzed within 5 mm from the edge of cell and their angle
relative to the leading edge was categorized as parallel if the track
was less than 45 degrees or perpendicular if more than 45 degrees.
For analysis of centrosome position in wound healing assays,
images of fixed cells stained for MTs, c-tubulin and DNA were
aligned with the wound parallel to the image x axis and lines were
plotted parallel to the image x axis to bisect each nucleus of cells at
the wound edge. Centrosomes in front of the line were considered
‘‘oriented’’.
Cell migration in wound healing assays was quantified by hand-
tracking the nucleus in time-lapse phase-contrast image series
using the ‘‘track points’’ function in MetaMorph software to
determine instantaneous velocity and distance to origin divided by
the total path length.
Statistical analysis was performed using the Analyze-It plug-in
(Analyze-It Software Ltd.) for Excel (Microsoft) or Matlab. Box
plots were used to represent the distributions of MT growth speed
and lifetime measurements under different conditions: red lines
represent median and boxes around them represent 25
th and 75
th
percentile of the dataset; 98% of the data points are inside the
whisker area and the residual outliers are represented by the red
points. For analysis of MT growth speed and lifetimes,
Kolmogorov-Smirnov test was used to analyze potential differ-
ences between the distributions of all measured MT growth
excursions pooled from all cells under each condition, and
Student’s t-test was used to analyze potential differences between
the distributions of mean values for each cell under each condition.
For centrosome position and cell migration velocity and
directionality measurements, Student’s t-test was used to analyze
potential differences between the distributions of mean values for
each condition.
Supporting Information
Figure S1 shRNA targeting of a distinct sequence of
MARK2 has similar effects on MT dynamics. An shRNA
vector with sequence targeting MARK2 (human par-1b) was
obtained from A. Suzuki [40]. (A) Top: Proportion of MT growth
excursions in subpopulations of CA-Rac1-transfected (CA-Rac1),
CA-Rac1 and MARK2 shRNA-transfected (+CA-Rac1, MARK2
RNAi #2), or CA-Rac1, MARK2 shRNA and GFP-MARK2-
transfected cells (+CA-Rac1, MARK2 RNAi #2+GFP-MARK2).
Bottom: Color key showing MT growth speed and growth
excursion lifetime ranges for subpopulations. Box-plots of speed
(B) and lifetime (C) of MT growth excursions, conditions as in A.
(*, p,0.001, Kolmogorov-Smirnov, *, p,0.05, Students).
(TIF)
Table S1 Mean MT growth speed and growth excursion
lifetimes. Control cells were transfected with control shRNA
vector; MARK2 shRNA vector was used for MARK2 RNAi.
Results of analysis of mKO-EB3 time-lapse movies using
PlusTipTracker software to measure MT growth dynamics. Data
shown is depicted graphically in Fig. 1D, 1E; Fig. 4D, 4E; Fig. 5C,
5D; Fig. 6B, 6C.
(DOC)
Table S2 Proportion of MT growth excursions in
subpopulations grouped according to growth speed
and growth excursion lifetime. Control cells were transfected
with control shRNA vector; MARK2 shRNA vector was used for
MARK2 RNAi. Data shown is depicted graphically in Fig. 1C,
Fig. 4C, Fig. 5B, Fig. 6A.
(DOC)
Table S3 Mean MT growth speed and growth excursion
lifetimes for cells treated with RNAis. shRNA vectors were
used for RNAi targeting of EB1, CLASP2, dynamitin, DCX,
MAP1A, MAP1B, MAP2, MAP4, MARK1, MARK2 and
MARK3. siRNA oligos were used for RNAi targeting of APC,
APC2, ACF7, XMAP215, Op18, p150
glued, CLIP115, CLIP170,
STOP, MAP1S, Spastin and Katanin p60. Results of analysis of
mKO-EB3 time-lapse movies using PlusTipTracker software to
measure MT growth dynamics.
(DOC)
Table S4 Proportion of MT growth excursions in
subpopulations grouped according to growth speed
and growth excursion lifetime for cells treated with
RNAsi. shRNA vectors were used for RNAi targeting of EB1,
CLASP2, dynamitin, DCX, MAP1A, MAP1B, MAP2, MAP4,
MARK1, MARK2 and MARK3. siRNA oligos were used for
RNAi targeting of APC, APC2, ACF7, XMAP215, Op18,
p150
glued, CLIP115, CLIP170, STOP, MAP1S, Spastin and
Katanin p60. Results of analysis of mKO-EB3 time-lapse movies
using PlusTipTracker software to measure MT growth dynamics.
Data shown is depicted graphically in Figure 2.
(DOC)
Table S5 Mean MT growth speed and growth excursion
lifetimes for cells expressing CA-Rac1 and treated with
RNAis. shRNA vectors were used for RNAi targeting of EB1,
CLASP2, dynamitin, DCX, MAP1A, MAP1B, MAP2, MAP4,
MARK1, MARK2 and MARK3. siRNA oligos were used for
RNAi targeting of APC, APC2, ACF7, XMAP215, Op18,
p150glued, CLIP115, CLIP170, STOP, MAP1S, Spastin and
Katanin p60. Results of analysis of mKO-EB3 time-lapse movies
using PlusTipTracker software to measure MT growth dynamics.
(DOC)
Table S6 Proportion of MT growth excursions in
subpopulations grouped according to growth speed
and growth excursion lifetime for cells expressing CA-
Rac1 and treated with RNAis. shRNA vectors were used for
RNAi targeting of EB1, CLASP2, dynamitin, DCX, MAP1A,
MAP1B, MAP2, MAP4, MARK1, MARK2 and MARK3. siRNA
oligos were used for RNAi targeting of APC, APC2, ACF7,
XMAP215, Op18, p150
glued, CLIP115, CLIP170, STOP, MAP1S,
Spastin and Katanin p60. Results of analysis of mKO-EB3 time-
lapse movies using PlusTipTracker software to measure MT
growth dynamics. Data shown is depicted graphically in Figure 3A.
(DOC)
Table S7 Orientation of MT growth at the leading edge.
shRNA vectors were used for control, and RNAi targeting of EB1
MARK2 Regulates Microtubules Downstream of Rac1
PLoS ONE | www.plosone.org 13 July 2012 | Volume 7 | Issue 7 | e41413and MARK2. siRNA oligos were used for RNAi targeting of
APC2, Op18, p150
glued and Spastin. mKO-EB3 tracks were
overlaid on images of mKO-EB3 using PlusTipTracker software
and the orientation of tracks within 5 mm from the leading edge
was classified according to their angle relative to the cell edge.
Data shown is depicted graphically in Figures. (Fig. 1G, Fig. 3C,
Fig. 4G, Fig. 5F, Fig. 6E).
(DOC)
Table S8 Mean MT growth speed and growth excursion
lifetimes in Figure S1. MARK2 shRNA #2 vector was used
for MARK2 RNAi. Results of analysis of mKO-EB3 time-lapse
movies using PlusTipTracker software to measure MT growth
dynamics. Data shown is depicted graphically in Figure S1B and
S1C.
(DOC)
Video S1 EB3 dynamics in U2-OS cells expressing Rac1
mutants. Spinning disk confocal fluorescence time-lapse image
sequences of cells expressing mKO-EB3 to mark growing MT plus
ends in cells expressing control non-targeting vector (WT, left),
CA-Rac1 (middle), and DN-Rac1 (right). The same cells are
shown in Figure 1F. Bar =10 mm, elapsed time in min: sec shown.
(MOV)
Video S2 EB3 dynamics in U2-OS cells treated with
shRNAs targeting MARK2. Spinning disk confocal fluores-
cence time-lapse image sequences of cells expressing mKO-EB3 to
mark growing MT plus ends in cells expressing shRNA targeting
MARK2 (left), CA-Rac1 and shRNA targeting MARK2 (middle)
or expressing CA-Rac1, shRNA targeting MARK2, and RNAi-
resistant GFP-MARK2 (right). The same cells are shown in
Figure 4F and Figure 5E. Bar =10 mm, elapsed time in min: sec.
(MOV)
Video S3 EB3 dynamics in control and MARK2 depleted
cells in a monolayer wound edge. Spinning disk confocal
fluorescence time-lapse image sequences of cells expressing mKO-
EB3 two hours after scratch-wounding a cell monolayer. Cells
treated with control shRNA (left), or MARK2 shRNA (right) at the
edge of a monolayer wound. The same cells are shown in
Figure 6D, bar =10 mm, elapsed time in min: sec.
(MOV)
Video S4 Effects of MARK2 depletion on directed cell
migration. Phase contrast time-lapse image series of U2-OS cells
treated with non-targeting siRNA pool (left) or MARK2 siRNA
(right). The same cells are shown in Figure 8C, bar =50 mm,
elapsed time after scratch-wounding shown in hr: min.
(MOV)
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